4.7 Article

Screening of a Halogen-Enriched Fragment Library Leads to Unconventional Binding Modes

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Multidisciplinary

Pushing the Limits of Characterising a Weak Halogen Bond in Solution

Stefan Peintner et al.

Summary: This study introduces a strategy for accurate experimental description of weak chemical forces in solution, demonstrating its scope and effectiveness through experiments. The methodology utilizes entropic advantage and ensemble analysis to describe the orientation of weak force interactions, and derives thermodynamic constants through temperature-dependent chemical shift analysis.

CHEMISTRY-A EUROPEAN JOURNAL (2022)

Article Chemistry, Medicinal

Fragment-to-Lead Medicinal Chemistry Publications in 2020

Iwan J. P. de Esch et al.

Summary: The review summarizes successful fragment-to-lead studies published in 2020 and discusses trends and best practices in fragment libraries, target proteins, screening technologies, hit-optimization strategies, and properties of hit fragments and leads. Trends and innovations identified in the review promise to further increase the success of FBDD by developing novel screening fragments, improving screening technologies, using computer-aided design and virtual screening, and combining FBDD with other drug-discovery technologies.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Multidisciplinary

Quadruple Target Evaluation of Diversity-Optimized Halogen-Enriched Fragments (HEFLibs) Reveals Substantial Ligand Efficiency for AP2-Associated Protein Kinase 1 (AAK1)

Marcel Dammann et al.

Summary: Fragment-based drug discovery efficiently covers a wide chemical space with few compounds, allowing diverse binding modes to be found. This approach has led to successful clinical candidates and approved drugs. Screening halogen-enriched fragments shows potential benefits in early drug discovery by acting as anchor points in the binding mode and providing valuable interactions. The use of such fragments in enzyme studies has shown promising results in identifying binding fragments and determining affinities for drug development.

FRONTIERS IN CHEMISTRY (2022)

Article Chemistry, Medicinal

Halogen Bonds Exist between Noncovalent Ligands and Natural Nucleic Acids

Kaijie Mu et al.

Summary: Based on database analysis and energy calculations, researchers have found that nucleic acids can serve as acceptors for halogen bonds and interact with noncovalent halogen ligands. They have confirmed the existence of halogen bonds in 13 systems, including two systems with relatively strong halogen bonds. By studying four model systems, they have also revealed the geometric rules for halogen bond formation in nucleic acids.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Comprehensive analysis of commercial fragment libraries

Julia Revillo Imbernon et al.

Summary: The screening of fragment libraries is crucial in drug discovery, with the success depending on the quality and design of the library meeting specific research requirements. This study conducted an inventory of commercial fragment libraries and developed a methodology to classify any library based on its similarity, coverage, and structural features, leading to the creation of a model that considers fragment diversity and ease of interpretation.

RSC MEDICINAL CHEMISTRY (2022)

Article Chemistry, Multidisciplinary

Pushing the Limits of Characterising a Weak Halogen Bond in Solution

Stefan Peintner et al.

Summary: This article presents a strategy for accurately describing weak chemical forces in solution, demonstrating the geometric and thermodynamic characterization of the weak halogen bond. By using a combination of NOE- and RDC-based ensemble analyses, this methodology allows for the precise orientation of donor and acceptor sites to be determined, paving the way for improved understanding and strategic use of weak forces in chemistry and biology.

CHEMISTRY-A EUROPEAN JOURNAL (2022)

Article Biochemistry & Molecular Biology

Synthesis, biological properties and structural study of new halogenated azolo [4,5-b]pyridines as inhibitors of CK2 kinase

K. Chojnacki et al.

Summary: New halogenated 1H-triazolo [4,5-b] pyridines and 1H-imidazo [4,5-b] pyridines were synthesized as analogues of known CK2 inhibitors, with di- and trihalogenated 1H-triazolo [4,5-bl] pyridines showing the highest activity against CK2 alpha. Compounds were also evaluated for their effect on the viability of cancer cell lines, and crystal structures of complexes with CK2 alpha and CK2 alpha' were obtained.

BIOORGANIC CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Identification of N,N-arylalkyl-picolinamide derivatives targeting the RNA-binding protein HuR, by combining biophysical fragment-screening and molecular hybridization

S. Della Volpe et al.

Summary: In this study, a biophysical fragment screening approach was used to identify promising small molecule fragments that interact with HuR, providing insights for the development of new therapeutic drugs. By designing and synthesizing compounds with interfering effects, the formation of the HuR-mRNA complex was successfully disrupted, offering a new strategy and pathway for rational modulation of RNA-binding protein activity.

BIOORGANIC CHEMISTRY (2021)

Article Chemistry, Physical

Halogen Atoms in the Protein-Ligand System. Structural and Thermodynamic Studies of the Binding of Bromobenzotriazoles by the Catalytic Subunit of Human Protein Kinase CK2

Honorata Czapinska et al.

Summary: The study investigated the interaction between a family of brominated benzotriazoles and the catalytic subunit of human protein kinase CK2. It found that halogen substitution increases affinity and affects ligand binding modes.

JOURNAL OF PHYSICAL CHEMISTRY B (2021)

Review Genetics & Heredity

Dyrk1a from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome

Helin Atas-Ozcan et al.

Summary: Research has identified Dyrk1a as the key driver gene in Down syndrome, playing a crucial role in brain development and neural function. Targeting DYRK1A overdosage with specific kinase inhibitors shows promising evidence for alleviating cognitive conditions in individuals with Down syndrome. However, addressing the developmental and neurodegenerative aspects of DS across the lifespan remains an open question.
Article Chemistry, Medicinal

Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors

Csaba Weber et al.

Summary: The kinase DYRK1A has been identified as a promising target for drug discovery, and a biaryl compound was developed through fragment screening to efficiently bind to its ATP site. Structural optimization cycles resulted in the transformation of this compound into potent and selective DYRK1A inhibitors, with a focus on fine-tuning selectivity by exploiting structural differences with DYRK2. These inhibitors demonstrated potent inhibition of DYRK1A in cell culture and in vivo, with drug-like properties and dose-dependent tumor growth inhibition in an ovarian carcinoma model.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B

David Lee Walmsley et al.

Summary: The serine/threonine kinase DYRK1A is associated with cancer progression and severity of symptoms in Down's syndrome. A highly selective and well-tolerated DYRK1A inhibitor has been identified, showing in vivo activity in a tumor model, and providing a useful tool for further research on the effects of DYRK1A inhibition in disease models.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library

Garrett S. Gibbons et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Editorial Material Pharmacology & Pharmacy

A bright future for fragment-based drug discovery: what does it hold?

Celien Jacquemard et al.

EXPERT OPINION ON DRUG DISCOVERY (2019)

Article Chemistry, Multidisciplinary

The nature of ligand efficiency

Peter W. Kenny

JOURNAL OF CHEMINFORMATICS (2019)

Article Chemistry, Multidisciplinary

Ranking Hits From Saturation Transfer Difference Nuclear Magnetic Resonance-Based Fragment Screening

Jonas Aretz et al.

FRONTIERS IN CHEMISTRY (2019)

Article Chemistry, Medicinal

Kinase Atlas: Druggability Analysis of Potential Allosteric Sites in Kinases

Christine Yueh et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Multidisciplinary Sciences

The nuclear interactome of DYRK1A reveals a functional role in DNA damage repair

Steven E. Guard et al.

SCIENTIFIC REPORTS (2019)

Article Biochemical Research Methods

Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix

Dorothee Liebschner et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2019)

Article Biochemistry & Molecular Biology

[b]-Annulated Halogen-Substituted Indoles as Potential DYRK1A Inhibitors

Christian Lechner et al.

MOLECULES (2019)

Article Chemistry, Medicinal

Predicting the Magnitude of σ-Holes Using VmaxPred, a Fast and Efficient Tool Supporting the Application of Halogen Bonds in Drug Discovery

Johannes Heidrich et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)

Article Chemistry, Medicinal

Scaffold Effects on Halogen Bonding Strength

Andreas Lange et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)

Article Biochemistry & Molecular Biology

Increasing Enzyme Stability and Activity through Hydrogen Bond-Enhanced Halogen Bonds

Anna-Carin C. Carlsson et al.

BIOCHEMISTRY (2018)

Article Chemistry, Medicinal

Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) Inhibitors

Anna Czarna et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

Halogen Bonding in Nucleic Acid Complexes

Michal H. Kolar et al.

JOURNAL OF MEDICINAL CHEMISTRY (2017)

Review Chemistry, Multidisciplinary

Computer Modeling of Halogen Bonds and Other σ-Hole Interactions

Michal H. Kolar et al.

CHEMICAL REVIEWS (2016)

Review Chemistry, Multidisciplinary

The Halogen Bond

Gabriella Cavallo et al.

CHEMICAL REVIEWS (2016)

Article Chemistry, Medicinal

Using Surface Scans for the Evaluation of Halogen Bonds toward the Side Chains of Aspartate, Asparagine, Glutamate, and Glutamine

Markus O. Zimmermann et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)

Article Chemistry, Medicinal

Probing the ATP-Binding Pocket of Protein Kinase DYRK1A with Benzothiazole Fragment Molecules

Ulli Rothweiler et al.

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Chemistry, Medicinal

Luciferin and derivatives as a DYRK selective scaffold for the design of protein kinase inhibitors

Ulli Rothweiler et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Chemistry, Medicinal

10-lodo-11H-indolo[3,2-c]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A

Hannes Falke et al.

JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Chemistry, Multidisciplinary

Targeting the Gatekeeper MET146 of C-Jun N-Terminal Kinase 3 Induces a Bivalent Halogen/Chalcogen Bond

Andreas Lange et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)

Article Biochemical Research Methods

NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy

Woonghee Lee et al.

BIOINFORMATICS (2015)

Article Chemistry, Medicinal

Halogen-enriched fragment libraries as chemical probes for harnessing halogen bonding in fragment-based lead discovery

Markus O. Zimmermann et al.

FUTURE MEDICINAL CHEMISTRY (2014)

Article Biotechnology & Applied Microbiology

The role of ligand efficiency metrics in drug discovery

Andrew L. Hopkins et al.

NATURE REVIEWS DRUG DISCOVERY (2014)

Article Biochemistry & Molecular Biology

Nmrglue: an open source Python package for the analysis of multidimensional NMR data

Jonathan J. Helmus et al.

JOURNAL OF BIOMOLECULAR NMR (2013)

Article Chemistry, Medicinal

Targeting Histidine Side Chains in Molecular Design through Nitrogen-Halogen Bonds

Andreas Lange et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)

Article Chemistry, Medicinal

Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology

Rainer Wilcken et al.

JOURNAL OF MEDICINAL CHEMISTRY (2013)

Article Biochemistry & Molecular Biology

Halogen bond tunability II: the varying roles of electrostatic and dispersion contributions to attraction in halogen bonds

Kevin E. Riley et al.

JOURNAL OF MOLECULAR MODELING (2013)

Article Chemistry, Physical

Halogen bonding and other sigma-hole interactions: a perspective

Peter Politzer et al.

PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2013)

Article Biochemistry & Molecular Biology

Structures of Down Syndrome Kinases, DYRKs, Reveal Mechanisms of Kinase Activation and Substrate Recognition

Meera Soundararajan et al.

STRUCTURE (2013)

Article Chemistry, Multidisciplinary

Halogen-Enriched Fragment Libraries as Leads for Drug Rescue of Mutant p53

Rainer Wilcken et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)

Article Biochemical Research Methods

Overview of the CCP4 suite and current developments

Martyn D. Winn et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)

Review Biochemistry & Molecular Biology

Activation, regulation, and inhibition of DYRK1A

Walter Becker et al.

FEBS JOURNAL (2011)

Article Biochemical Research Methods

XDS

Wolfgang Kabsch

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)

Article Biochemical Research Methods

Features and development of Coot

P. Emsley et al.

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)

Article Multidisciplinary Sciences

Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A

Yasushi Ogawa et al.

NATURE COMMUNICATIONS (2010)

Article Chemistry, Multidisciplinary

Design and NMR-Based Screening of LEF, a Library of Chemical Fragments with Different Local Environment of Fluorine

Anna Vulpetti et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)

Article Chemistry, Multidisciplinary

Phaser crystallographic software

Airlie J. McCoy et al.

JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)

Article Biochemistry & Molecular Biology

Halogen bonding:: the σ-hole

Timothy Clark et al.

JOURNAL OF MOLECULAR MODELING (2007)